Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKR) Asset Utilization Ratio (2011 - 2026)

Bruker posted quarterly Asset Utilization Ratio of 0.01 for Q1 2026, down 98.87% year-on-year from 0.59 in Q1 2025, and up 119.86% on a QoQ basis from 0.0 in Q4 2025.

Bruker (BRKR) has 16 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio fell 98.87% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (down 98.87% YoY), and the FY2025 full-year result was 0.0, down 99.52% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.01, up from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.75 in Q3 2022 and bottomed at 0.0 in Q4 2025.
  • The 5-year median for Asset Utilization Ratio is 0.68 (2022), against an average of 0.58.
  • The widest annual swing landed in 2023, when Asset Utilization Ratio increased 4.09%; it then plunged 99.46% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.73 in 2022, then climbed by 0.87% to 0.73 in 2023, then retreated by 23.12% to 0.56 in 2024, then slumped by 99.46% to 0.0 in 2025, then soared by 119.86% to 0.01 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.0 (Q4 2025), and 0.54 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Bruker 8.89 Bn 8.77 Bn 379.80 Mn 0.01

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.00
Sep 30, 2025 0.54
Jun 30, 2025 0.56
Mar 31, 2025 0.59
Dec 31, 2024 0.56
Sep 30, 2024 0.54
Jun 30, 2024 0.60
Mar 31, 2024 0.69
Dec 31, 2023 0.73
Sep 30, 2023 0.73
Jun 30, 2023 0.71
Mar 31, 2023 0.71
Dec 31, 2022 0.73
Sep 30, 2022 0.75
Jun 30, 2022 0.71
Mar 31, 2022 0.68
Dec 31, 2021 0.71
Sep 30, 2021 0.76
Jun 30, 2021 0.74
Mar 31, 2021 0.70
Dec 31, 2020 0.67
Sep 30, 2020 0.67
Jun 30, 2020 0.67
Mar 31, 2020 0.71
Dec 31, 2019 0.81
Sep 30, 2019 0.86
Jun 30, 2019 0.86
Mar 31, 2019 0.88
Dec 31, 2018 0.94
Sep 30, 2018 1.01
Jun 30, 2018 1.01
Mar 31, 2018 0.96
Dec 31, 2017 0.90
Sep 30, 2017 0.88
Jun 30, 2017 0.89
Mar 31, 2017 0.89
Dec 31, 2016 0.89
Sep 30, 2016 0.92
Jun 30, 2016 0.94
Mar 31, 2016 0.95
Dec 31, 2015 0.91
Sep 30, 2015 0.90
Jun 30, 2015 0.93
Mar 31, 2015 0.96
Dec 31, 2014 0.96
Sep 30, 2014 0.95
Jun 30, 2014 0.93
Mar 31, 2014 0.93
Dec 31, 2013 0.94
Sep 30, 2013 0.97
Jun 30, 2013 1.00
Mar 31, 2013 0.97
Dec 31, 2012 0.98
Sep 30, 2012 0.99
Jun 30, 2012 0.97
Mar 31, 2012 0.97
Dec 31, 2011 0.98
Sep 30, 2011 0.95
Jun 30, 2011 0.89
Mar 31, 2011 0.87